Skip to content

Co-Principal Investigator’s Overview of First-in-Human Clinical Study

← All Posts

The first-in-human clinical study for OSSIOfiber Intelligent Bone Regeneration Technology was a multicenter, prospective, single-arm study designed to primarily focus on proving the safety and efficacy of the material technology for hammertoe correction arthrodesis. 

At 6 months, the study’s results were published in Foot & Ankle Orthopaedic Journal. Hear co-principal investigator, Luke Cicchinelli, DPM, speak to the results of the clinical study at the 1 year time point, which is currently pending publication. 

  • Fusion rate about historical averages 
  • No adverse complications 
  • All measurable scores (FAAM-ADL, Pain VAS) improved from baseline
  • 100% patient satisfaction and willingness to recommend OSSIOfiber to others 

DOC0001415 Rev 01 11/2020

Luke Cicchinelli, DPM

Luke Cicchinelli, DPM

Luke Cicchinelli, DPM, received his medical degree at Pennsylvania College of Podiatric Medicine and completed his residency for reconstructive foot, ankle, and leg surgery at Emory Northlake Regional Medical Center in Atlanta, GA. He is a Fellow of the American College of Foot and Ankle Surgeons, Australian College of Podiatric Surgery, and has been a guest lecturer across the world. Currently, he is a member of Colegiado en Galicia and Asturias Spain and practices throughout multiples clinics in Spain as a freelance consultant surgeon, coach, and educator. In addition, Dr. Cicchinelli is one of the primary investigators for the first-in-human clinical study for OSSIOfiber Intelligent Bone Regeneration Technology.

Related Posts

Case Study: A Clinical Approach to Treating Hammertoe Deformities with a Bio-Integrative Fixation Implant

Hammertoe deformities are one of the most common foot deformities, estimated to affect one third of the population.1 Intramedullary implants have gained popularity over the past decade, with the advantage of avoiding an external, percutanous K-wire during the rehabilitation phase. There are many on the market, manufactured from a variety of implant materials including conventionalContinue reading “Case Study: A Clinical Approach to Treating Hammertoe Deformities with a Bio-Integrative Fixation Implant”

Ossio Faculty July 7, 2021

First-in-Human, Prospective, Multicenter Clinical Study

OSSIO is thrilled to announce the publication of our prospective, multicenter, first-in-human clinical trial in Foot & Ankle Orthopaedics.  Prospective, Multicenter, Clinical and Radiographic Evaluation of a Biointegrative, Fiber-Reinforced Implant for Proximal Interphalangeal Joint ArthrodesisLuke D. Cicchinelli, DPM, Jurij Štalc, MD, Martinus Richter, MD, PhD, Stuart Miller, MD Twenty-five patients underwent PIPJ fusions with OSSIOfiber HammertoeContinue reading “First-in-Human, Prospective, Multicenter Clinical Study”

ASPS Webinar

Earn CECH credits by watching this recent webinar, hosted with American Society of Podiatric Surgeons and presenter Bob Baravarian, DPM, FACFAS.  NOW ON-DEMAND WEBINAR: The Science and Clinical Experience with Strong and Bio-Integrative Implant Fixation Speaker: Bob Baravarian, DPM, FACFAS   Hear Dr. Baravarian present on: Science behind the strong and bio-integrative OSSIOfiber Technology First-in-humanContinue reading “ASPS Webinar”

Bob Baravarian, DPM November 3, 2020

Interested in OSSIOfiber®?

Complete the form and an OSSIOfiber® Advisor will get in touch.

Customer Service

For product inquiries or purchasing questions contact 833-781-7373 or email info@ossio.io

Address

Commercial Headquarters
OSSIO Inc
300 Tradecenter Drive, Suite 3690
Woburn, MA, 01801

Science & Manufacturing Center

OSSIO Ltd.
8 HaTochen Street
Cesarea, Israel 3079861

OSSIOfiber® has been used by surgeons across the US

Footnotes

1. Data on file at OSSIO 2. Clinical study data on file at OSSIO 3. Kaiser, P.B., Watkins, I., Riedel, M. D., Cronin, P., Briceno, J., Kron, J. Y. (2019). Implant Removal Matrix for the Foot and Ankle Orthopaedic Surgeon. Foot & Ankle Specialist, 12(1), 79-97. https://doi.org/10.1177/1938640018791015 4. Pre-clinical animal studies (in-bone implantation of OSSIOfiber® and PLDLA control in rabbit femurs). Data on File at OSSIO. 5.Haddad, S. F., Helm, M. M., Meath, B., Adams, C., Packianathan, N., & Uhl, R. (2019). Exploring the Incidence, Implications, and Relevance of Metal Allergy to Orthopaedic Surgeons. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 3(4), e023. https://doi.org/10.5435/JAAOSGlobal-D-19-00023